Sage Therapeutics to Present at Upcoming September Investor Conferences

September 6, 2023 6:30 AM EDT

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following upcoming investor conferences in September:

  • Morgan Stanley 21st Annual Global Healthcare Conference (New York, NY): fireside chat on Wednesday, September 13, 2023 at 12:15 p.m. ET.
  • TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit (Virtual): fireside chat on Wednesday, September 20, 2023 at 3:00 p.m. ET.

A live webcast of each event can be accessed on the Investor page of Sage’s website at A replay of the webcasts will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit

Ashley Kaplowitz
[email protected]

Media Contact
Matthew Henson
[email protected]

Source: Sage Therapeutics, Inc.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Business Wire, Press Releases

Related Entities

Morgan Stanley, Cowen & Co